Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126515281 | 12651528 | 1 | I | 20160804 | 20160815 | 20160815 | EXP | CA-APOTEX-2016AP010380 | APOTEX | 15.00 | YR | F | Y | 0.00000 | 20160815 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126515281 | 12651528 | 1 | PS | ATORVASTATIN | ATORVASTATIN | 1 | Oral | U | 90548 | TABLET | |||||||||
| 126515281 | 12651528 | 2 | SS | APO-LANSOPRAZOLE | LANSOPRAZOLE | 1 | Oral | U | 0 | CAPSULE | |||||||||
| 126515281 | 12651528 | 3 | SS | APO-MYCOPHENOLATE | MYCOPHENOLIC ACID | 1 | Oral | U | 0 | ||||||||||
| 126515281 | 12651528 | 4 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | U | 0 | ||||||||||
| 126515281 | 12651528 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | U | 0 | TABLET | |||||||||
| 126515281 | 12651528 | 6 | SS | APO-SULFATRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | U | 0 | ||||||||||
| 126515281 | 12651528 | 7 | SS | APO-VORICONAZOLE | VORICONAZOLE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
| 126515281 | 12651528 | 8 | SS | APO-VORICONAZOLE | VORICONAZOLE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
| 126515281 | 12651528 | 9 | SS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | U | 0 | ||||||||||
| 126515281 | 12651528 | 10 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | U | 0 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126515281 | 12651528 | 1 | Product used for unknown indication |
| 126515281 | 12651528 | 2 | Product used for unknown indication |
| 126515281 | 12651528 | 3 | Prophylaxis against transplant rejection |
| 126515281 | 12651528 | 4 | Product used for unknown indication |
| 126515281 | 12651528 | 5 | Product used for unknown indication |
| 126515281 | 12651528 | 6 | Product used for unknown indication |
| 126515281 | 12651528 | 7 | Fungal infection |
| 126515281 | 12651528 | 9 | Product used for unknown indication |
| 126515281 | 12651528 | 10 | Prophylaxis against transplant rejection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126515281 | 12651528 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126515281 | 12651528 | Actinic keratosis | |
| 126515281 | 12651528 | Drug interaction | |
| 126515281 | 12651528 | Photodermatosis | |
| 126515281 | 12651528 | Photosensitivity reaction | |
| 126515281 | 12651528 | Solar lentigo | |
| 126515281 | 12651528 | Squamous cell carcinoma of skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |